Operating Company Healthcare

EVERSANA

Chicago, Illinois, United States

EVERSANA is an independent provider of integrated global services to the life sciences industry, delivering solutions across the product life cycle to drive long-term value for patients, prescribers, channel partners and payers.

Focus Areas
Life sciences commercialization, Market access, Patient support

Tracked deals

9

9 tracked deals across 2019-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

9 buyout

EVERSANA Acquisition Volume by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for EVERSANA. 2 2019 2 2020 3 2021 1 2023 1 2025

Supporting Data

Recent Transactions

  • Buyer
    EVERSANA
    Target
    Waltz Health
    Type
    Buyout

    EVERSANA announced a merger with Waltz Health to combine EVERSANA’s end-to-end pharmaceutical commercialization services with Waltz’s AI-driven prescription routing and payer-facing marketplace technology. Mark Thierer, co-founder and CEO of Waltz Health, will serve as CEO of the combined organization as the companies integrate capabilities to improve drug affordability, payer connectivity and patient access for specialty and high-cost therapies.

  • Buyer
    EVERSANA
    Target
    Healthware Group
    Location
    Campania, Italy
    Type
    Buyout

    EVERSANA has acquired Healthware Group, a Salerno-headquartered full-service healthcare agency and innovation consultancy, expanding EVERSANA's European operations and integrating Healthware into its EVERSANA INTOUCH global agency network. Healthware (150+ employees) will bring marketing, medical communications, digital innovation, and media assets — including the Frontiers Health conference and pharmaphorum — into EVERSANA; Roberto Ascione joins EVERSANA's global leadership. Financial terms were not disclosed.

  • Buyer
    EVERSANA
    Target
    Intouch Group
    Type
    Buyout

    EVERSANA has completed its acquisition of Intouch Group, a global full-service agency network serving the pharmaceutical industry. The deal integrates Intouch’s creative, media, enterprise solutions and data analytics into EVERSANA’s commercialization services platform to expand capabilities and accelerate digital-first commercialization for life sciences clients.

  • October 15, 2021
    Buyer
    EVERSANA
    Target
    Protean
    Type
    Buyout

    EVERSANA has acquired Protean, a market access consulting firm that specializes in channel and trade, patient services and payer contracting operations. The deal integrates Protean’s operational experts and proprietary tools into EVERSANA’s consulting and commercial services to expand market access, channel and patient services capabilities for life sciences clients.

  • Buyer
    EVERSANA
    Target
    Accelera Canada, Patient Access Solutions, Podium Strategic Partners, Inc., Advocacy Solutions
    Seller
    Michael Cloutier, Charles Pirraglia, Deborah Brown, Lindy Forte, Ryan Clarke
    Location
    Ontario, Canada
    Type
    Buyout

    EVERSANA acquired Toronto-based Accelera Canada and its partner companies Patient Access Solutions, Podium Strategic Partners, Inc., and Advocacy Solutions to expand its commercial services footprint in Canada. The deal adds market access, patient advocacy and patient-support capabilities to EVERSANA's global life sciences commercialization platform and brings several Accelera founding partners and staff into EVERSANA's Canadian team.

  • Buyer
    EVERSANA
    Target
    Alkemy Partners
    Type
    Buyout

    EVERSANA, a Chicago-based provider of commercial services to the life science industry, has acquired Alkemy Partners, a New Hampshire–based field learning and development firm that provides training, content creation and digital solutions for market access, sales and clinical engagement. The deal expands EVERSANA's field solutions and training capabilities — adding medical writing, training facilitation, leadership development and multimedia/digital learning capabilities to its commercial services platform. Financial terms were not disclosed.

  • Buyer
    EVERSANA
    Target
    HVH Precision Analytics
    Seller
    Havas Health & You, Perspecta
    Industry
    Data & Analytics
    Type
    Buyout

    EVERSANA has acquired HVH Precision Analytics and its predictive AI/ML analytics platform from prior owners Havas Health & You and Perspecta. The acquisition brings a military-grade predictive analytics capability into EVERSANA's integrated commercial services for life sciences, while an exclusive strategic partnership will maintain client continuity with Havas Health & You; financial terms were not disclosed.

  • Buyer
    EVERSANA
    Target
    Cornerstone Research Group
    Location
    Ontario, Canada
    Type
    Buyout

    EVERSANA has agreed to acquire Canada-based Cornerstone Research Group, a health economics and outcomes research (HEOR) firm headquartered in Burlington, Ontario. The acquisition adds HEOR, economic modeling, evidence synthesis and market access capabilities to EVERSANA’s integrated commercial services platform to better support pharmaceutical and medical device clients globally.

  • Buyer
    EVERSANA
    Target
    Alamo Pharma Services, Inc., BexR Logistix, LLC (Telesales)
    Seller
    Mission Pharmacal Company
    Location
    United States
    Type
    Buyout

    EVERSANA has acquired Alamo Pharma Services, Inc. and the BexR Logistix telesales business from Mission Pharmacal Company to bolster its Field Solutions capabilities. Alamo (Doylestown, Pennsylvania) and BexR Telesales (Broomfield, Colorado) will transition to the EVERSANA brand, with Alamo COO Peter Marchesini named president, Field Solutions; financial terms were not disclosed.

Related Acquisition Pages

Selling a company? Get in front of buyers like EVERSANA

Turn tracked acquisition activity into an outreach-ready buyer list.